BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 25251874)

  • 1. Anisotropic growth-induced synthesis of dual-compartment Janus mesoporous silica nanoparticles for bimodal triggered drugs delivery.
    Li X; Zhou L; Wei Y; El-Toni AM; Zhang F; Zhao D
    J Am Chem Soc; 2014 Oct; 136(42):15086-92. PubMed ID: 25251874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anisotropic encapsulation-induced synthesis of asymmetric single-hole mesoporous nanocages.
    Li X; Zhou L; Wei Y; El-Toni AM; Zhang F; Zhao D
    J Am Chem Soc; 2015 May; 137(18):5903-6. PubMed ID: 25909815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled synthesis of uniform and monodisperse upconversion core/mesoporous silica shell nanocomposites for bimodal imaging.
    Liu J; Bu W; Zhang S; Chen F; Xing H; Pan L; Zhou L; Peng W; Shi J
    Chemistry; 2012 Feb; 18(8):2335-41. PubMed ID: 22252972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Facile Multi-interface Transformation Approach to Monodisperse Multiple-Shelled Periodic Mesoporous Organosilica Hollow Spheres.
    Teng Z; Su X; Zheng Y; Zhang J; Liu Y; Wang S; Wu J; Chen G; Wang J; Zhao D; Lu G
    J Am Chem Soc; 2015 Jun; 137(24):7935-44. PubMed ID: 26030506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrospun upconversion composite fibers as dual drugs delivery system with individual release properties.
    Hou Z; Li X; Li C; Dai Y; Ma P; Zhang X; Kang X; Cheng Z; Lin J
    Langmuir; 2013 Jul; 29(30):9473-82. PubMed ID: 23855606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silica composite nanoparticles containing fluorescent solid core and mesoporous shell with different thickness as drug carrier.
    Ran Z; Sun Y; Chang B; Ren Q; Yang W
    J Colloid Interface Sci; 2013 Nov; 410():94-101. PubMed ID: 24011559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facile Synthesis of Yolk-Shell-Structured Triple-Hybridized Periodic Mesoporous Organosilica Nanoparticles for Biomedicine.
    Teng Z; Zhang J; Li W; Zheng Y; Su X; Tang Y; Dang M; Tian Y; Yuwen L; Weng L; Lu G; Wang L
    Small; 2016 Jul; 12(26):3550-8. PubMed ID: 27183872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-conversion nanoparticle assembled mesoporous silica composites: synthesis, plasmon-enhanced luminescence, and near-infrared light triggered drug release.
    Niu N; He F; Ma P; Gai S; Yang G; Qu F; Wang Y; Xu J; Yang P
    ACS Appl Mater Interfaces; 2014 Mar; 6(5):3250-62. PubMed ID: 24521281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.
    Li C; Yang D; Ma P; Chen Y; Wu Y; Hou Z; Dai Y; Zhao J; Sui C; Lin J
    Small; 2013 Dec; 9(24):4150-9. PubMed ID: 23843254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation-Restructuring Induced Anisotropic Epitaxial Growth for Fabrication of Asymmetric Diblock and Triblock Mesoporous Nanocomposites.
    Li X; Zhao T; Lu Y; Wang P; El-Toni AM; Zhang F; Zhao D
    Adv Mater; 2017 Aug; 29(30):. PubMed ID: 28605063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
    Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
    Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Assembled Upconversion Nanoparticle Clusters for NIR-controlled Drug Release and Synergistic Therapy after Conjugation with Gold Nanoparticles.
    Cai H; Shen T; Kirillov AM; Zhang Y; Shan C; Li X; Liu W; Tang Y
    Inorg Chem; 2017 May; 56(9):5295-5304. PubMed ID: 28402112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-Time Monitoring of ATP-Responsive Drug Release Using Mesoporous-Silica-Coated Multicolor Upconversion Nanoparticles.
    Lai J; Shah BP; Zhang Y; Yang L; Lee KB
    ACS Nano; 2015 May; 9(5):5234-45. PubMed ID: 25859611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fabrication of Rhenium Disulfide/Mesoporous Silica Core-Shell Nanoparticles for a pH-Responsive Drug Release and Combined Chemo-Photothermal Therapy.
    Na H; Carrier J; Oyon S; Lai CY
    ACS Appl Bio Mater; 2024 May; 7(5):3337-3345. PubMed ID: 38700956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-Hybrid-Gated Photothermal Mesoporous Silica Nanoparticles for NIR-Responsive and Aptamer-Targeted Drug Delivery.
    Zhang Y; Hou Z; Ge Y; Deng K; Liu B; Li X; Li Q; Cheng Z; Ma P; Li C; Lin J
    ACS Appl Mater Interfaces; 2015 Sep; 7(37):20696-706. PubMed ID: 26325285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amine-functionalized, porous silica-coated NaYF
    Reddy KL; Sharma PK; Singh A; Kumar A; Shankar KR; Singh Y; Garg N; Krishnan V
    Mater Sci Eng C Mater Biol Appl; 2019 Mar; 96():86-95. PubMed ID: 30606601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH and Ultrasound Dual-Responsive Polydopamine-Coated Mesoporous Silica Nanoparticles for Controlled Drug Delivery.
    Li X; Xie C; Xia H; Wang Z
    Langmuir; 2018 Aug; 34(34):9974-9981. PubMed ID: 30056720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-pore mesoporous carbon@silica composite core-shell nanospheres for multidrug delivery.
    Fang Y; Zheng G; Yang J; Tang H; Zhang Y; Kong B; Lv Y; Xu C; Asiri AM; Zi J; Zhang F; Zhao D
    Angew Chem Int Ed Engl; 2014 May; 53(21):5366-70. PubMed ID: 24764082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple function nanocomposites of porous silica-CoFe
    Fan H; Xing X; Yang Y; Li B; Wang C; Qiu D
    Dalton Trans; 2017 Nov; 46(43):14831-14838. PubMed ID: 29043319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional core-shell structured nanocarriers for synchronous tumor diagnosis and treatment in vivo.
    Chen YY; Ma PA; Yang DM; Wu Y; Dai YL; Li CX; Lin J
    Chem Asian J; 2014 Feb; 9(2):506-13. PubMed ID: 24227257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.